ICM
VC icon

Invenomic Capital Management’s Visteon VC Stock Holding History

Invenomic Capital Management’s Portfolio VC Stock Details VC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,278
Closed -$2.85M – 163
2026
Q1 		$2.85M Buy
+31,278
New +$2.96M 0.13% 121
2025
Q3 		– Sell
-62,941
Closed -$5.87M – 182
2025
Q2 		$5.87M Buy
62,941
+12,082
+24% +$994K 0.33% 91
2025
Q1 		$3.95M Buy
+50,859
New +$4.28M 0.2% 127

Other funds holding VC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Invenomic Capital Management's VC Position: Q2 2026 in Review

Invenomic Capital Management sold out of Visteon (VC) in Q2 2026, closing a stake of 31,278 shares — an estimated $2.85M sold.

Invenomic Capital Management first reported a position in VC in Q1 2025 and held it in 3 quarters. The position peaked at $5.87M in Q2 2025. 319 funds tracked by Wall St. Rank hold VC as of Q2 2026.

  • Invenomic Capital Management reported no remaining Visteon position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 31,278 Visteon shares in Q2 2026, an estimated $2.85M.
  • Invenomic Capital Management first reported a position in Visteon in Q1 2025 and held it in 3 quarters.
  • Invenomic Capital Management's Visteon position peaked at $5.87M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Visteon as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.